Past speaker Peter Sturtevant, Sr. Director of Industry Engagement at GS1 US, discusses the tools which will help you achieve and surpass DSCSA compliance, such as the Electronic Product Code Information Service and the Master Data Exchange.
As serialization and track-and-trace capabilities go mainstream to meet regulatory compliance mandates, pharmaceuticals companies should simultaneously explore how these tools and techniques can improve supply chain planning and operations, elevate patient and doctor engagement, and increase sales and marketing effectiveness. Whitepaper courtesy of Cognizant.
Check out this webinar from Ben Locwin of Healthcare Sciences Advisors!
Take a look at this exclusive whitepaper put together by VideoJet. Within the paper you will find out more about how the DQSA and DSCSA compliance regulations can impact your overall operation.
This white paper gives in-depth descriptions of the:
- Challenges driving new serialization regulation.
- Pending regulation requirements and deadlines.
- Implementation and interoperability challenges in serialization solutions.
- New holistic serialization solution from Rockwell Automation built on a modular and scalable off-the-shelf control and information platform.
- Business benefits of the common data source created by serialization.
Are you ready? The likely answer is no, but it’s just as likely that you are working on it. The fact is, the pharmaceutical industry is still wrestling with challenges which will continue to evolve as serialization systems are rolled out.
Take sneek peak at the 7 steps to implementing a full serialization project:
1: Get ready for a cultural change.
2: Invest in high volume items
At the 6th Pharmaceutical Traceability Forum, Optel made an exciting industry announcement. Watch the live video here..
Currently, the pharmaceutical industry uses tracking and tracing technology heavily in the upstream supply chain. Maintaining visibility of the source of Active Pharmaceutical Ingredients (API) is of utmost importance.
Editor’s Note: Every year, 40 or so students in the MIT Center for Transportation & Logistics’ (MIT CTL) Master of Supply Chain Management (SCM) program complete one-year thesis research projects. The students are early-career business professionals from multiple countries with 2 to 10 years of experience in the industry. Most of the research projects are chosen, sponsored by, and carried out in collaboration with multinational corporations. Joint teams that include MIT SCM students and MIT CTL faculty work on the real-world problems. In this series, we summarize a selection of the latest SCM research. The SCM thesis Serialization of Prescription Drugs in the US: A Centralized View was authored by Aisha Nabiyeva and David Z. Y. Wu, and supervised by Dr. Bruce Arntzen, Executive Director, Supply Chain Management Program, MIT Center for Transportation & Logistics.
By 2020, pharma cold chain logistics spend is anticipated to exceed $16 billion. Despite this massive investment, pharmaceutical supply chains still face tremendous challenges. We sat down with Jack Shaw, Executive Director of the American Blockchain Council, Technology Futurist to discuss this matter, as well as:
- The direct impact blockchain has on the pharma supply chain
- The impact blockchain technology will have on cold chain logistics
- How cold chain pharmaceuticals is preparing for future technologies
We spoke with the Associate Director of Supply Chain Management at Merck, who gave us a deep dive look into end-to-end supply chain visibility.
Blockchain is the new buzzword in supply chain circles. Unfortunately, there are many examples of much-hyped innovations that promised to transform supply chains overnight, only to peter out or take much longer to gain traction than originally claimed.
Is blockchain technology any different? We are still early in the process of answering that question.
We spoke with Brian Files to discuss the largest challenges and implications in integrating serialization into the supply chain, what 2024 and beyond will look like, how new technologies will affect us, the major issues anticipated after the 2018 goal is met and more. Brian is a Principal Consultant at Healthcare Strategies Consulting Group and was formerly the Supply Chain Policy and Compliance Director at CVS Health.